ESR1 and breast cancer: Since HDACs are also components of estrogen receptor complexes and HDAC inhibitors have been reported to be able to restore sensitivity of breast cancer cells to tamoxifen [44], this may explain, in part, why ING1 levels are able to predict survival in non-luminal forms of breast cancer as we report here for the first time.